Capital VC posts HK$8.57 million interim loss despite rights-issue boost to net assets

Bulletin Express
May 28

Capital VC (02324) released unaudited results for the six months ended 31 March 2026, showing a wider net loss but a stronger balance sheet after a rights issue.

Revenue and Earnings • Turnover was negative HK$1.11 million (2025: negative HK$0.28 million), reflecting a HK$9.43 million combined realised and unrealised loss on listed equity investments that outweighed HK$8.32 million of dividend and interest income. • Administrative expenses rose 41.6% year on year to HK$7.18 million. • Finance costs fell 21.3% to HK$1.48 million. • Net loss attributable to shareholders widened to HK$8.57 million, versus a HK$7.23 million loss a year earlier. • Basic and diluted loss per share were HK1.57 cents (2025: HK1.43 cents).

Balance Sheet and Cash Flow • Net asset value (NAV) increased 10.1% to HK$482.77 million, driven mainly by HK$52.75 million net proceeds from a March 2026 rights issue. • NAV per share declined to HK$0.54 (30 September 2025: HK$0.97) after the share base doubled to 900.26 million shares. • Cash and cash equivalents grew to HK$50.42 million from HK$38.26 million at year-end. • Net current assets stood at HK$376.11 million, giving a current ratio of 12.3 (30 September 2025: 11.5). • Interest-bearing borrowings totalled HK$31.11 million, trimming the gearing ratio to 6.4% (30 September 2025: 8.0%). • Operating activities used HK$41.39 million in cash; financing inflows of HK$52.75 million offset the deficit, leaving a HK$12.16 million net increase in cash.

Investment Portfolio Performance • Listed equities: Net realised loss of HK$2.01 million and net unrealised loss of HK$7.42 million produced a HK$9.43 million drag on turnover. Key negative contributors included Vision Synergy (HK$10.50 million unrealised loss) and WLS Holdings (HK$7.90 million unrealised loss); gains were led by BFB Health (HK$12.10 million) and Tai Kam Holdings (HK$10.40 million). • Bonds: Interest income reached HK$7.85 million. Two bonds (HK$22.20 million principal) were redeemed, while six new bonds (HK$56.00 million principal) were acquired. Total investments in financial assets at amortised cost rose to HK$201.20 million (30 September 2025: HK$169.45 million) after a HK$1.20 million reversal of expected credit losses. • Significant holdings at period-end included: – 18.5 million shares of Asia Strategy Digit Technology (fair value HK$56.60 million, 11.0% of total assets); – Gold Medal Hong Kong bond portfolio (carrying value HK$65.91 million, 12.8%); – Hao Wen Holdings bonds (carrying value HK$31.89 million, 6.2%). • Approximately HK$76.10 million of listed securities were pledged against margin facilities.

Capital Actions • A capital reorganisation and 1-for-1 rights issue were completed on 13 March 2026, issuing 450.13 million new shares at HK$0.12 each and raising HK$52.75 million net. Proceeds are earmarked for listed equity investments, unlisted debt investments, and working capital.

Outlook Management signalled a cautious stance amid an unpredictable global environment but will continue to seek opportunities in listed and unlisted securities. The company reported no material commitments, contingent liabilities, or foreign-currency hedge contracts as of 31 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10